Ubiquitin Ligase COP1 Suppresses Neuroinflammation by Degrading c/EBPβ in Microglia.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
03 09 2020
Historique:
received: 07 04 2020
revised: 09 06 2020
accepted: 10 07 2020
pubmed: 17 8 2020
medline: 8 5 2021
entrez: 16 8 2020
Statut: ppublish

Résumé

Dysregulated microglia are intimately involved in neurodegeneration, including Alzheimer's disease (AD) pathogenesis, but the mechanisms controlling pathogenic microglial gene expression remain poorly understood. The transcription factor CCAAT/enhancer binding protein beta (c/EBPβ) regulates pro-inflammatory genes in microglia and is upregulated in AD. We show expression of c/EBPβ in microglia is regulated post-translationally by the ubiquitin ligase COP1 (also called RFWD2). In the absence of COP1, c/EBPβ accumulates rapidly and drives a potent pro-inflammatory and neurodegeneration-related gene program, evidenced by increased neurotoxicity in microglia-neuronal co-cultures. Antibody blocking studies reveal that neurotoxicity is almost entirely attributable to complement. Remarkably, loss of a single allele of Cebpb prevented the pro-inflammatory phenotype. COP1-deficient microglia markedly accelerated tau-mediated neurodegeneration in a mouse model where activated microglia play a deleterious role. Thus, COP1 is an important suppressor of pathogenic c/EBPβ-dependent gene expression programs in microglia.

Identifiants

pubmed: 32795415
pii: S0092-8674(20)30876-X
doi: 10.1016/j.cell.2020.07.011
pii:
doi:

Substances chimiques

CCAAT-Enhancer-Binding Protein-beta 0
CEBPB protein, human 0
Ubiquitin 0
COP1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Ligases EC 6.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1156-1169.e12

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests All authors were employees of Genentech.

Auteurs

Ada Ndoja (A)

Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA.

Rohit Reja (R)

Department of Bioinformatics and Computational Biology, Genentech, South San Francisco, CA 94080, USA.

Seung-Hye Lee (SH)

Department of Neuroscience, Genentech, South San Francisco, CA 94080, USA.

Joshua D Webster (JD)

Department of Pathology, Genentech, South San Francisco, CA 94080, USA.

Hai Ngu (H)

Department of Pathology, Genentech, South San Francisco, CA 94080, USA.

Christopher M Rose (CM)

Department of Microchemistry, Proteomics, Lipidomics and Next Generation Sequencing, Genentech, South San Francisco, CA 94080, USA.

Donald S Kirkpatrick (DS)

Department of Microchemistry, Proteomics, Lipidomics and Next Generation Sequencing, Genentech, South San Francisco, CA 94080, USA.

Zora Modrusan (Z)

Department of Microchemistry, Proteomics, Lipidomics and Next Generation Sequencing, Genentech, South San Francisco, CA 94080, USA.

Ying-Jiun Jasmine Chen (YJ)

Department of Microchemistry, Proteomics, Lipidomics and Next Generation Sequencing, Genentech, South San Francisco, CA 94080, USA.

Debra L Dugger (DL)

Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA.

Vineela Gandham (V)

Department of Biomedical Imaging, Genentech, South San Francisco, CA 94080, USA.

Luke Xie (L)

Department of Biomedical Imaging, Genentech, South San Francisco, CA 94080, USA.

Kim Newton (K)

Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA. Electronic address: knewton@gene.com.

Vishva M Dixit (VM)

Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA. Electronic address: dixit@gene.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH